tradingkey.logo


tradingkey.logo


Koninklijke Philips NV

PHG
27.330USD
-0.110-0.40%
取匕時間 ET15分遅れの株䟡
26.00B時䟡総額
25.68盎近12ヶ月PER


Koninklijke Philips NV

27.330
-0.110-0.40%

詳现情報 Koninklijke Philips NV 䌁業名

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.

Koninklijke Philips NVの䌁業情報


䌁業コヌドPHG
䌚瀟名Koninklijke Philips NV
䞊堎日Sep 18, 2009
最高経営責任者「CEO」Jakobs (Roy)
埓業員数67823
蚌刞皮類Depository Receipt
決算期末Sep 18
本瀟所圚地High Tech Campus 5
郜垂EINDHOVEN
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜Netherlands
郵䟿番号5656 AE
電話番号31205977777
りェブサむトhttps://www.philips.com/
䌁業コヌドPHG
䞊堎日Sep 18, 2009
最高経営責任者「CEO」Jakobs (Roy)

Koninklijke Philips NVの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Marnix van Ginneken, Ph.D.
Dr. Marnix van Ginneken, Ph.D.
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
--
--
Dr. Paulus A. (Paul) Stoffels
Dr. Paulus A. (Paul) Stoffels
Independent Vice Chairman of the Supervisory Board, Secretary
Independent Vice Chairman of the Supervisory Board, Secretary
--
--
Mr. A. Marc Harrison
Mr. A. Marc Harrison
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Roy Jakobs
Mr. Roy Jakobs
Chairman of the Board of Management, Chief Executive Officer
Chairman of the Board of Management, Chief Executive Officer
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Mr. Leandro Mazzoni
Mr. Leandro Mazzoni
Head of Investor Relations
Head of Investor Relations
--
--
Ms. Deeptha Khanna
Ms. Deeptha Khanna
Executive Vice President, Chief Business Leader Personal Health
Executive Vice President, Chief Business Leader Personal Health
--
--
Mr. Peter Loescher
Mr. Peter Loescher
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Feike Sijbesma
Mr. Feike Sijbesma
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Marnix van Ginneken, Ph.D.
Dr. Marnix van Ginneken, Ph.D.
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
--
--
Dr. Paulus A. (Paul) Stoffels
Dr. Paulus A. (Paul) Stoffels
Independent Vice Chairman of the Supervisory Board, Secretary
Independent Vice Chairman of the Supervisory Board, Secretary
--
--
Mr. A. Marc Harrison
Mr. A. Marc Harrison
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Roy Jakobs
Mr. Roy Jakobs
Chairman of the Board of Management, Chief Executive Officer
Chairman of the Board of Management, Chief Executive Officer
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
North America
2.14B
42.61%
Growth geographies
1.42B
28.29%
Western Europe
1.09B
21.69%
Other Mature geographies
374.02M
7.44%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Wed, Mar 4
曎新時刻: Wed, Mar 4
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Mondrian Investment Partners Ltd.
0.83%
Fiduciary Management, Inc.
0.69%
Dimensional Fund Advisors, L.P.
0.47%
Fidelity Management & Research Company LLC
0.27%
Causeway Capital Management LLC
0.23%
他の
97.51%
株䞻統蚈
株䞻統蚈
比率
Mondrian Investment Partners Ltd.
0.83%
Fiduciary Management, Inc.
0.69%
Dimensional Fund Advisors, L.P.
0.47%
Fidelity Management & Research Company LLC
0.27%
Causeway Capital Management LLC
0.23%
他の
97.51%
皮類
株䞻統蚈
比率
Investment Advisor
4.05%
Investment Advisor/Hedge Fund
0.77%
Research Firm
0.25%
Hedge Fund
0.15%
Family Office
0.07%
Family Office
0.04%
Family Office
0.04%
Bank and Trust
0.02%
Venture Capital
0.01%
他の
94.59%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
586
50.66M
5.33%
-12.53M
2025Q3
564
51.04M
5.37%
-17.40M
2025Q2
560
58.95M
6.20%
-8.73M
2025Q1
579
60.52M
6.54%
-8.45M
2024Q4
583
60.06M
6.49%
-29.02M
2024Q3
590
63.64M
6.83%
-28.01M
2024Q2
594
65.28M
6.99%
-29.22M
2024Q1
610
73.19M
7.82%
-21.31M
2023Q4
642
73.00M
7.79%
-18.85M
2023Q3
666
68.56M
7.24%
-21.16M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Mondrian Investment Partners Ltd.
7.91M
0.83%
+794.94K
+11.18%
Sep 30, 2025
Fiduciary Management, Inc.
7.18M
0.75%
-284.22K
-3.81%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
4.44M
0.47%
-56.61K
-1.26%
Sep 30, 2025
Fidelity Management & Research Company LLC
2.60M
0.27%
+171.68K
+7.08%
Sep 30, 2025
Causeway Capital Management LLC
1.96M
0.21%
+107.12K
+5.79%
Sep 30, 2025
Parametric Portfolio Associates LLC
1.83M
0.19%
+109.23K
+6.35%
Sep 30, 2025
Northern Trust Global Investments
1.64M
0.17%
+121.24K
+7.99%
Sep 30, 2025
Brandes Investment Partners, L.P.
1.62M
0.17%
+87.72K
+5.73%
Sep 30, 2025
Aperio Group, LLC
1.29M
0.14%
+13.78K
+1.08%
Sep 30, 2025
Envestnet Asset Management, Inc.
1.30M
0.14%
-51.03K
-3.78%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Langar Global HealthTech ETF
5.12%
Brandes International ETF
1.99%
Brandes US Small-Mid Cap Value ETF
1.17%
ActivePassive International Equity ETF
0.24%
DFA Dimensional Intl Sustainability Core 1 ETF
0.14%
Avantis Responsible International Equity ETF
0.12%
State Street SPDR S&P Kensho New Econ Comp ETF
0.1%
DFA Dimensional International Core Equity 2 ETF
0.09%
Avantis International Equity ETF
0.08%
Dimensional International Core Equity Market ETF
0.07%
詳现を芋る
Langar Global HealthTech ETF
比率5.12%
Brandes International ETF
比率1.99%
Brandes US Small-Mid Cap Value ETF
比率1.17%
ActivePassive International Equity ETF
比率0.24%
DFA Dimensional Intl Sustainability Core 1 ETF
比率0.14%
Avantis Responsible International Equity ETF
比率0.12%
State Street SPDR S&P Kensho New Econ Comp ETF
比率0.1%
DFA Dimensional International Core Equity 2 ETF
比率0.09%
Avantis International Equity ETF
比率0.08%
Dimensional International Core Equity Market ETF
比率0.07%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™